The DOI matches its Crossref record, with a small difference in title or year; 54 of the 56 references it cites were found in a registry or an index.
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Open accessAbstract
CONTEXT: Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. OBJECTIVE: To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. DATA SOURCES: PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. STUDY SELECTION: Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. DATA EXTRACTION: Individual patient-level data were obtained from study authors. RESULTS: Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. CONCLUSIONS: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antidepressants have been demonstrated efficient in treating MDD”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size.45 For mild to severe depression the effect estimates ranged from -0.17 to -0.11; this is lower than the effect size for smoking cessation.”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For SSRIs, researchers have argued that a substantial portion of the perceived therapeutic benefit in double-blind randomized clinical trials (RCTs) may stem from placebo responses rather than the drug itself (Sugarman et al., 2014; Fournier et al., 2010; Kirsch, 2014; Moncrieff and Kirsch, 2015).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Fournier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The introduction and widespread use of selective serotonine uptake inhibitors (SSRI) [22, 23] and psychological therapy including cognitive behavioral therapy (CBT) [24, 25] meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.”
From Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: A population-based study (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“there are differences in individual response”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
From One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. (2020) · cites this paper as [34]
In the citing paper
“Two individual participant data meta-analysis (26, 27) indicated that patients with lower baseline severity would achieve smaller improvement compared to placebo.”
In the citing paper
“Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.8–10”
In the citing paper
“Thus, the benefits of antidepressants in non-severe depression have been argued to be minimal.8 11”
In the citing paper
“One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression,20 but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity .44–46”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [20]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“Although antidepressants are unlikely to be effective in most presentations of distress (18), physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“The strength of the pooled standardised mean difference in change was clinically important - the association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
In the citing paper
“A meta-analysis of individual-level data from randomised controlled trials (RCTs) of antidepressants for”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,421
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Research works printed but not linked: 1
- [3]Depression Guideline Panel Depression in primary care: Vol. 2. Treatment of major depression Clinical Practice Guideline No. 5. AHCPR Publication No. 93-0551 Rockville, MD U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research 1993
Cited by
Sorted by citations
Items 701–800 of 1,006
Cronin, C. J., Forsstrom, M. P., & Papageorge, N. (2020) · National Bureau of Economic Research · doi:10.3386/w27711 · Cited by 28
Hellerstein, D. J., & Flaxer, J. M. (2015) · Core evidence · doi:10.2147/ce.s54075 · Cited by 27
Liu, Y., Hui, F., Mo, Y., Jingfang, G., Hongjing, M., Mingfen, S., Shengdong, W., Yan, Y., & Wenjuan, L. (2015) · 中医杂志：英文版 · doi:10.1016/s0254-6272(15)30132-1 · Cited by 27
Should antidepressants be used in minor depression?
Naber, D., & Bullinger, M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/dnaber · Cited by 26
Donald, M., Partanen, R. L., Sharman, L. S., Lynch, J. M., Dingle, G. A., Haslam, C., & van Driel, M. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2020.0913 · Cited by 30
Forman‐Hoffman, V. L., Nelson, B. W., Ranta, K., Nazander, A., Hilgert, O., & Quevedo, J. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100408 · Cited by 27
Antidepressants Are Not Overprescribed for Mild Depression
Simon, G. E., Rossom, R. C., Beck, A. L., Waitzfelder, B. E., Coleman, K. J., Stewart, C. C., Operskalski, B. H., Penfold, R. B., & Shortreed, S. M. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09162 · Cited by 27
Gili, M., Vicens, C., Roca, M., Andersen, P., & McMillan, D. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.07.035 · Cited by 28
Palmer, S. C., Taggi, A., DeMichele, A. M., & Coyne, J. C. (2011) · Cancer · doi:10.1002/cncr.26603 · Cited by 28
Jerant, A. F., Kravitz, R. L., y García, E. F., Feldman, M. D., Cipri, C., Nishio, D., Knoepfler, A., Wooddell, M. K., Baquero, V. H., & Franks, P. J. (2014) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2014.05.140038 · Cited by 26
How to choose an antidepressant medication
Bayes, A. J., & Parker, G. B. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13001 · Cited by 29
So, H., Chau, C. K., Lau, A., Wong, S., & Zhao, K. (2018) · Psychological Medicine · doi:10.1017/s0033291718003641 · Cited by 29
van der Burg, K. P., Cribb, L., Firth, J., Karmacoska, D., & Sarris, J. J. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1625222 · Cited by 28
Kurhe, Y., & Mahesh, R. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.004 · Cited by 28
Recommendations for Screening for Depression in Adults
Thase, M. E. (2016) · JAMA · doi:10.1001/jama.2015.18406 · Cited by 27
Shook, J. J., Goodkind, S., Herring, D., Pohlig, R. T., Kolivoski, K., & Kim, K. H. (2013) · Children and Youth Services Review · doi:10.1016/j.childyouth.2012.09.017 · Cited by 27
“Do antidepressants work?” A humanistic perspective on a long-standing and contentious debate.
Cosgrove, L., Troeger, R., & Karter, J. M. (2019) · The Humanistic Psychologist · doi:10.1037/hum0000154 · Cited by 26
Chang, H. S., Won, E., Lee, H.-Y., Ham, B., Kim, Y.-G., & Lee, M.-S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1333-9 · Cited by 25
Kikuchi, T., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.007 · Cited by 24
Challenges of creating synergy between global mental health and cultural psychiatry
de Jong, J. T. V. M. (2014) · Transcultural Psychiatry · doi:10.1177/1363461514557995 · Cited by 28
Krivoy, A., Stubbs, B., Balicer, R. D., Weizman, S., Feldman, B., Hoshen, M., Zalsman, G., Hochman, E., & Shoval, G. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.428 · Cited by 26
Samara, M. T., Goldberg, Y., Levine, S. Z., Furukawa, T. A., Geddes, J. R., Cipriani, A., Davis, J. M., & Leucht, S. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30331-0 · Cited by 26
A meta-analysis of cranial electrotherapy stimulation in the treatment of depression
Price, L. R., Briley, J., Haltiwanger, S., & Hitching, R. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.043 · Cited by 28
de Anta, L., Álvarez-Mon, M. Á., Álvarez-Mon, M. Á., Salazar, C., Donat‐Vargas, C., Santoma-Vilaclara, J., Martin-Martinez, M., Lahera, G., Gutiérrez-Rojas, L., Rodríguez–Jiménez, R., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020155 · Cited by 26
He, R., Wei, J., Huang, K., Yang, H., Chen, Y., Liu, Z., Ma, L., Jia, Y., & Chen, L. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114897 · Cited by 29
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. N., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0274-7 · Cited by 27
McGirr, A., den Eynde, F. V., Chachamovich, E., Fleck, M. P., & Berlim, M. T. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.01.037 · Cited by 27
Does psychoanalysis have a valuable place in modern mental health services? Yes
Fonagy, P., & Lemma, A. (2012) · BMJ · doi:10.1136/bmj.e1211 · Cited by 26
Kim, J.-M., Stewart, R. J., Bae, K. S., Kang, H.-J., Kim, S.-W., Shin, I.-S., Hong, Y. J., Ahn, Y., Jeong, M. H., & Yoon, J.-S. (2014) · Psychological Medicine · doi:10.1017/s003329171400275x · Cited by 27
Soucy, I., Provencher, M. D., Fortier, M., & McFadden, T. (2017) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2017.1337806 · Cited by 26
Adler, U. C., Krüger, S., Teut, M., Lüdtke, R., Schützler, L., Martins, F., Willich, S. N., Linde, K., & Witt, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074537 · Cited by 26
Tolin, D. F. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.08.007 · Cited by 25
Nature-based interventions: a systematic review of reviews
Kaleta, B., Campbell, S., O’Keeffe, J., & Burke, J. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1625294 · Cited by 25
Nonpharmacological treatment of postmenopausal symptoms
Tong, I. L. (2013) · The Obstetrician & Gynaecologist · doi:10.1111/j.1744-4667.2012.00143.x · Cited by 26
Hollon, S. D. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000748 · Cited by 27
Self-citationUnexamined assumptions and unintended consequences of routine screening for depression
Cosgrove, L., Karter, J. M., Vaswani, A., & Thombs, B. D. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.03.007 · Cited by 26
Purinergic transmission in depressive disorders
Szopa, A., Socała, K., Serefko, A., Doboszewska, U., Wróbel, A., Poleszak, E., & Właź, P. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107821 · Cited by 25
Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Dold, M., Swoboda, M. M. M., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01368-3 · Cited by 26
Diagnosis and Treatment of Depression in Adults With Comorbid Medical Conditions
Whooley, M. A. (2012) · JAMA · doi:10.1001/jama.2012.3466 · Cited by 26
Hegerl, U., Allgaier, A., Henkel, V., & Mergl, R. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.015 · Cited by 25
Qian, X., Zhou, X., You, Y., Shu, S., Fang, F., Huang, S., & Zhou, S. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2015.0084 · Cited by 25
Krishna, M., Lepping, P., Jones, S., & Lane, S. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.05.043 · Cited by 28
Is Exercise an Efficacious Treatment for Depression? A Comment upon Recent Negative Findings
Schuch, F., & Fleck, M. P. D. A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00020 · Cited by 27
Telephone-Based Behavioral Health Assessment for Older Adults Starting a New Psychiatric Medication
Maust, D. T., Mavandadi, S., Eakin, A. C., Streim, J. E., DiFilippo, S. D., Snedden, T. M., & Oslin, D. W. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318202c1dc · Cited by 25
Screening, diagnosis, and treatment of depression.
Greenberg, J., Tesfazion, A. A., & Robinson, C. S. (2012) · Military Medicine · doi:10.7205/milmed-d-12-00102 · Cited by 35
Klein, J. P., Späth, C., Schröder, J., Meyer, B., Greiner, W., Hautzinger, M., Lutz, W., Rose, M., Vettorazzi, E., Andersson, G., et al. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.07.013 · Cited by 25
Ross, S. M. (2017) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000241 · Cited by 25
A discrete-choice experiment to assess treatment modality preferences of patients with depression
Lokkerbol, J., Geomini, A., van Voorthuijsen, J., van Straten, A., Tiemens, B. G., Smit, F., Risseeuw, A., & Hiligsmann, M. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2018.1555404 · Cited by 25
Roh, D. D., Jung, J. H., Yoon, K. H., Lee, C. H., Kang, L. Y., Lee, S., Shin, K., & Kim, D. H. (2019) · Phytotherapy Research · doi:10.1002/ptr.6286 · Cited by 25
Verdoux, H., Cougnard‐Grégoire, A., Thiébaut, A. C. M., & Tournier, M. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1271686 · Cited by 25
Meng, X., & D’Arcy, C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.007 · Cited by 31
Fox, A. S., Chang, L. J., Gorgolewski, K. J., & Yarkoni, T. (2014) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/012310 · Cited by 26
Randomized Controlled Trial of the Marriage Checkup: Depression Outcomes
Gray, T. D., Hawrilenko, M., & Cordova, J. V. (2020) · Journal of Marital and Family Therapy · doi:10.1111/jmft.12411 · Cited by 24
Evolução do perfil motor de autistas após intervenção psicomotora breve
Alves, L. M. D. S., Santos, N. M. D. F., & de Castro, G. G. (2022) · Fisioterapia Brasil · doi:10.33233/fb.v23i3.4873 · Cited by 24
Chen, G., Guo, Z., Chen, P., Yang, Z., Yan, H., Sun, S., Ma, W., Zhang, Y., Qi, Z., Fang, W., et al. (2024) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2024.100483 · Cited by 24
Ilieva, I. P. (2014) · Neuroethics · doi:10.1007/s12152-014-9226-z · Cited by 24
Lauridsen, M. G., & Sporrong, S. K. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.07.011 · Cited by 24
Monden, R., Roest, A. M., van Ravenzwaaij, D., Wagenmakers, E., Morey, R. D., Wardenaar, K. J., & de Jonge, P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.040 · Cited by 24
Iglesias-González, M., Aznar‐Lou, I., Peñarrubia‐María, M. T., Gil‐Girbau, M., Fernández‐Vergel, R., Alonso, J., Serrano‐Blanco, A., & Rubio-Valera, M. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.005 · Cited by 24
Krishna, M., Honagodu, A., Rajendra, R., Sundarachar, R., Lane, S., & Lepping, P. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3905 · Cited by 24
What It Takes to Defend Deceptive Placebo Use
Barnhill, A. (2011) · Kennedy Institute of Ethics journal · doi:10.1353/ken.2011.0015 · Cited by 24
Comorbidity between migraine and depression: update on traditional and alternative treatments
Baskin, S. M., & Smitherman, T. A. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0549-9 · Cited by 23
Depression in Late-Life: A Focus on Prevention
Okereke, O. I., Lyness, J. M., Lotrich, F. E., & Reynolds, C. F. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.22 · Cited by 25
Hopko, D. R., Clark, C. G., Cannity, K. M., & Bell, J. L. (2015) · Health Psychology · doi:10.1037/hea0000252 · Cited by 24
Zisook, S., Tal, I., Weingart, K. R., Hicks, P. B., Davis, L. L., Chen, P., Yoon, J., Johnson, G. R., Vertrees, J. E., Rao, S. D., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.023 · Cited by 25
Bangratz, M., Abdellah, S. A., Berlin, A., Blondeau, C., Guilbot, A., Dubourdeaux, M., & Lemoine, P. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s169575 · Cited by 24
Hollon, S. D., DeRubeis, R. J., Andrews, P. W., & Thomson, J. A. (2020) · Cognitive Therapy and Research · doi:10.1007/s10608-020-10132-1 · Cited by 24
Self-citationDindo, L. N., Recober, A., Calarge, C. A., Zimmerman, B. M., Weinrib, A., Marchman, J. N., & Turvey, C. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00818-0 · Cited by 24
Mathai, D. S., Hull, T. D., Vando, L., & Malgaroli, M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.131 · Cited by 27
Xu, F., Yang, H. J., Chen, J., Wu, Q., Gong, W., Zhang, J., Shao, W., Mu, J., Yang, D., Yang, Y., et al. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0543-y · Cited by 23
Ethical considerations in clinical training, care and research in psychopharmacology
Strous, R. D. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001112 · Cited by 23
REMOVED: Exercise as antidepressant treatment: Time for the transition from trials to clinic?
Panteleimon Ekkekakis, A., & Murri, M. B. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.008 · Cited by 28
RetractedSamochowiec, J., Dudek, D., Kucharska–Mazur, J., Murawiec, S., Rymaszewska, J., Cubała, W. J., Heitzman, J., Szulc, A., Bała, M. M., & Gałecki, P. (2021) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/132496 · Cited by 29
Depression is associated with hippocampal volume loss in adults with HIV
Bronshteyn, M., Yang, F. N., Shattuck, K. F., Dawson, M., Kumar, P. N., Moore, D. J., Ellis, R. J., & Jiang, X. (2021) · Human Brain Mapping · doi:10.1002/hbm.25451 · Cited by 25
Brehaut, E., Neupane, D., Levis, B., Wu, Y., Sun, Y. B., Ioannidis, J. P. A., Markham, S., Cuijpers, P. J., Patten, S. B., Benedetti, A., et al. (2022) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1956 · Cited by 27
Gensichen, J. S., Lukaschek, K., Jung‐Sievers, C., Falkai, P., Schmitt, A., Henningsen, P., Dreischulte, T., Pitschel‐Walz, G., Krcmar, H., Böhm, M., et al. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01913-6 · Cited by 23
Chang, H. S., Won, E., Lee, H.-Y., Ham, B., & Lee, M.-S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.005 · Cited by 24
Verdoux, H., Cortaredona, S., Dumesnil, H., Sebbah, R., & Verger, P. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0717-8 · Cited by 24
Ohtsuki, T., Inagaki, M., Oikawa, Y., Saitoh, A., Kurosawa, M., Muramatsu, K., & Yamada, M. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-30 · Cited by 23
Stewart, J. G., & Harkness, K. L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.015 · Cited by 23
Accounting for Behavior in Treatment Effects: New Applications for Blind Trials
Chassang, S., Snowberg, E., Seymour, B., & Bowles, C. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127227 · Cited by 23
Roose, S. P., Rutherford, B. R., Wall, M. M., & Thase, M. E. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.163261 · Cited by 23
Kao, C.-Y., He, Z., Henes, K., Asara, J. M., Webhofer, C., Filiou, M. D., Khaitovich, P., Wotjak, C. T., & Turck, C. W. (2016) · Complex Psychiatry · doi:10.1159/000445377 · Cited by 24
SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli
Preuss, A., Bolliger, B., Schicho, W., Hättenschwiler, J., Seifritz, E., Brühl, A. B., & Herwig, U. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.538393 · Cited by 22
“042), which may be associated to the fact that antidepressants have been proven more efficient in moderate to severe depression (1).”
BackgroundInfluentialNunes, E. V., Covey, L. S., Brigham, G., Hu, M.-C., Levin, F. R., Somoza, E. C., & Winhusen, T. M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08155 · Cited by 22
Tran, L., Sharrad, K., Kopsaftis, Z., Stallman, H. M., Tai, A., Spurrier, N., Esterman, A., & Carson-Chahhoud, K. (2021) · Journal of Asthma · doi:10.1080/02770903.2020.1731826 · Cited by 22
Locher, C., Kossowsky, J., Gaab, J., Kirsch, I., Bain, P. A., & Krummenacher, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.062 · Cited by 23
Individual response to antidepressants for depression in adults-a meta-analysis and simulation study
Munkholm, K., Homan, S., & Homan, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237950 · Cited by 23
Alwhaibi, A. M., Alsanea, S., Almadi, B., Alsabhan, J. F., & Alosaimi, F. D. (2022) · The Aging Male · doi:10.1080/13685538.2022.2053954 · Cited by 22
Hicks, A. J., Clay, F. J., James, A. C., Hopwood, M., & Ponsford, J. L. (2022) · Neuropsychology Review · doi:10.1007/s11065-022-09543-6 · Cited by 23
EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder
Oakley, T., Coskuner, J., Cadwallader, A., Ravan, M., & Hasey, G. (2022) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2022.3204861 · Cited by 22
Factors impacting the medication “Adherence Landscape” for transplant patients
Bendersky, V. A., Saha, A., Sidoti, C. N., Ferzola, A., Downey, M. C., Ruck, J. M., Vanterpool, K. B., Young, L., Shegelman, A., Segev, D. L., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.14962 · Cited by 22
Neurosteroid influence on affective tone
Walton, N. L., Antonoudiou, P., & Maguire, J. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105327 · Cited by 23
Tong, X., Xie, H., Wu, W., Keller, C. J., Fonzo, G. A., Chidharom, M., Carlisle, N. B., Etkin, A., & Zhang, Y. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.177 · Cited by 22
Internetbasierte psychologische Behandlung bei Depressionen
Klein, J. P., & Berger, T. (2013) · Verhaltenstherapie · doi:10.1159/000354046 · Cited by 23
The Power of Belief and Expectancy in Understanding and Management of Depression
Alladin, A. (2013) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2012.740607 · Cited by 22
Mohamed, S., Johnson, G. R., Vertrees, J. E., Guarino, P., Weingart, K. R., Young, I. T., Yoon, J., Gleason, T., Kirkwood, K. A., Kilbourne, A. M., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.08.005 · Cited by 22
Šestan-Peša, M., & Horváth, T. L. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.12.003 · Cited by 21
Farabaugh, A. H., Fisher, L. B., Nyer, M., Holt, D. J., Cohen, M., Baer, L., Shapero, B. G., Huz, I., Cardoos, A., D, M. F. M., et al. (2015) · Annals of Clinical Psychiatry · doi:10.1177/104012371502700206 · Cited by 22
Mental Illness and Mental Health: Is the Glass Half Empty or Half Full?
Pierre, J. M. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205701102 · Cited by 22
Metadata
- Authors
- Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J.
- Affiliations
- University of Pennsylvania (US)
- University of New Mexico (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-06
- Volume
- 303
- Issue
- 1
- Pages
- 47
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3712503
- OpenAlex
- W2004762037
- Cited by
- 2,009
- References
- 56
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 89 · 2023: 70 · 2022: 81 · 2021: 134 · 2020: 81 · 2019: 111 · 2018: 143 · 2017: 128 · 2016: 112 · 2015: 149 · 2014: 154 · 2013: 170 · 2012: 172
- FWCI
- 144.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Alliance for Research on Schizophrenia and Depression
- Universiteit Maastricht
- National Institute of Mental Health (K24MH001741, R10 MH50129, R01MH060998, K02MH001697, R10MH055875, R10MH055877)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, depression severity, placebo response, Hamilton Depression Rating Scale, treatment effect heterogeneity, mild depression, antidepressant efficacy
- MeSH terms
- Adult, Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
